AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (399.4 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Publishing Language: Chinese

Research progress on underlying mechanism of traditional Chinese medicine in treatment of immune checkpoint inhibitor-induced colitis

Chanchan Zhang1, Jianfei Sun2( ), Gang Xiao3, Hui Guo3, Hang Ren1
Faculty of Clinical Medicine of Integrated Chinese and Western Medicine, College of Integrated Chinese and Western Medicine, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China
College of Continuing Education, Shaanxi University of Chinese Medicine, Xianyang 712046, Shaanxi Province, China
Department of General Surgery, Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang 712000, Shaanxi Province, China
Show Author Information

Abstract

Tumor immunotherapy has profoundly transformed the therapeutic landscape for many advanced malignancies. However, with the increasing clinical application of immune checkpoint inhibitors (ICI), a spectrum of immune-related adverse events (irAEs) has emerged, among which ICI-induced colitis is one of the most common gastrointestinal irAEs. In severe cases, it can lead to treatment interruption and even patient death. The current mainstay treatments, glucocorticoids and biological agents, are often associated with inconsistent efficacy, significant side effects, and a risk of recurrence. In recent years, traditional Chinese medicine (TCM) has demonstrated unique advantages in treating ICI-induced colitis through its multi-target and holistic regulatory approach. In this article, based on advanced domestic and international literature, we systematically elaborated the potential mechanisms of traditional Chinese medicine and its active components in treatment of ICI-induced colitis, from the aspects of regulating regulatory T cell/T helper 17 cell balance, modulating macrophage polarization, restoring T helper 1 cell/T helper 2 cell balance, and improving gut microbiota, aiming to provide new ideas and references for alleviating irAEs and improving patient′s quality of life.

CLC number: R730.6; R285.5; R574.62 Document code: A

References

【1】
【1】
 
 
Chinese Journal of Multiple Organ Diseases in the Elderly
Pages 157-160

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Zhang C, Sun J, Xiao G, et al. Research progress on underlying mechanism of traditional Chinese medicine in treatment of immune checkpoint inhibitor-induced colitis. Chinese Journal of Multiple Organ Diseases in the Elderly, 2026, 25(2): 157-160. https://doi.org/10.11915/j.issn.1671-5403.2026.02.034

2

Views

0

Downloads

0

Crossref

Received: 19 May 2025
Accepted: 07 August 2025
Published: 28 February 2026
© 2026 Chinese Journal of Multiple Organ Diseases in the Elderly